# Aquestive Therapeutics, Inc.: filings

AQST · Nasdaq · CIK 1398733 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aqst.md) · [Financials](/companies/aqst/financials.md) · [Filings](/companies/aqst/filings.md) · [Insiders](/companies/aqst/insiders.md)

## Reports and events: 226 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 284, 8-K 182, 3 29, 10-Q 25, 144 18, CORRESP 15, 424B5 13, DEFA14A 10, UPLOAD 10, S-8 9, 10-K 8, 4/A 8, DEF 14A 8, EFFECT 7, SC 13G/A 7, S-3 6, SC 13G 5, ARS 4, SCHEDULE 13G/A 3, 424B2 2, 424B3 2, CT ORDER 2, S-1/A 2, SCHEDULE 13G 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-1 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:04 ET | [8-K](/filings/0001398733-26-000063.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001398733-26-000063 |
| 2026-10-15 | 11:21 ET | [8-K](/filings/0001398733-26-000058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000058 |
| 2026-10-14 | 11:21 ET | [8-K](/filings/0001398733-26-000056.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001398733-26-000056 |
| 2026-09-29 | 11:22 ET | [8-K](/filings/0001398733-26-000052.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001398733-26-000052 |
| 2026-09-25 | 11:59 ET | [8-K](/filings/0001398733-26-000048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000048 |
| 2026-09-17 | 11:02 ET | [8-K](/filings/0001398733-26-000044.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001398733-26-000044 |
| 2026-08-11 | 20:10 ET | [10-Q](/filings/0001398733-26-000042.md) | Quarterly report, period 2026-06-30 | 0001398733-26-000042 |
| 2026-08-11 | 20:06 ET | [8-K](/filings/0001398733-26-000041.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000041 |
| 2026-08-10 | 11:05 ET | [8-K](/filings/0001398733-26-000035.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001398733-26-000035 |
| 2026-06-10 | 20:02 ET | [8-K](/filings/0001398733-26-000033.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001398733-26-000033 |
| 2026-05-13 | 20:08 ET | [10-Q](/filings/0001398733-26-000030.md) | Quarterly report, period 2026-03-31 | 0001398733-26-000030 |
| 2026-05-13 | 20:04 ET | [8-K](/filings/0001398733-26-000029.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000029 |
| 2026-04-24 | 21:00 ET | [DEF 14A](/filings/0001140361-26-016757.md) | Proxy statement, period 2026-06-10 | 0001140361-26-016757 |
| 2026-03-30 | 11:44 ET | [8-K](/filings/0001398733-26-000022.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000022 |
| 2026-03-20 | 11:36 ET | [8-K](/filings/0001398733-26-000020.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000020 |
| 2026-03-04 | 21:21 ET | [10-K](/filings/0001398733-26-000018.md) | Annual report, period 2025-12-31 | 0001398733-26-000018 |
| 2026-03-04 | 21:10 ET | [8-K](/filings/0001398733-26-000016.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000016 |
| 2026-02-26 | 13:07 ET | [8-K](/filings/0001398733-26-000007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000007 |
| 2026-02-02 | 12:03 ET | [8-K](/filings/0001398733-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-26-000005 |
| 2026-01-09 | 12:18 ET | [8-K](/filings/0001398733-26-000003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001398733-26-000003 |
| 2025-11-06 | 21:01 ET | [8-K](/filings/0001398733-25-000030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000030 |
| 2025-11-05 | 21:07 ET | [10-Q](/filings/0001398733-25-000028.md) | Quarterly report, period 2025-09-30 | 0001398733-25-000028 |
| 2025-11-05 | 21:04 ET | [8-K](/filings/0001398733-25-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000027 |
| 2025-10-08 | 11:23 ET | [8-K](/filings/0001398733-25-000022.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001398733-25-000022 |
| 2025-10-01 | 12:41 ET | [8-K](/filings/0001398733-25-000020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000020 |
| 2025-09-08 | 12:32 ET | [8-K](/filings/0001398733-25-000018.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000018 |
| 2025-09-04 | 11:11 ET | [8-K](/filings/0001398733-25-000016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000016 |
| 2025-08-15 | 01:37 ET | [8-K](/filings/0001140361-25-031374.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-031374 |
| 2025-08-14 | 10:26 ET | [8-K](/filings/0001140361-25-031008.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-031008 |
| 2025-08-11 | 20:11 ET | [10-Q](/filings/0001398733-25-000013.md) | Quarterly report, period 2025-06-30 | 0001398733-25-000013 |
| 2025-08-11 | 20:05 ET | [8-K](/filings/0001398733-25-000012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001398733-25-000012 |
| 2025-07-15 | 11:54 ET | [8-K](/filings/0001628280-25-034890.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-034890 |
| 2025-06-16 | 11:48 ET | [8-K](/filings/0001628280-25-031455.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-031455 |
| 2025-06-11 | 21:21 ET | [8-K](/filings/0001628280-25-030804.md) | 5.07 Shareholder vote results | 0001628280-25-030804 |
| 2025-06-02 | 20:03 ET | [8-K](/filings/0001628280-25-028813.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-028813 |
| 2025-05-12 | 20:07 ET | [10-Q](/filings/0001628280-25-024664.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024664 |
| 2025-05-12 | 20:05 ET | [8-K](/filings/0001628280-25-024659.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-024659 |
| 2025-04-25 | 20:31 ET | [DEF 14A](/filings/0001140361-25-015781.md) | Proxy statement, period 2025-06-11 | 0001140361-25-015781 |
| 2025-04-01 | 12:26 ET | [8-K](/filings/0001628280-25-015759.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-015759 |
| 2025-03-10 | 12:10 ET | [8-K](/filings/0001628280-25-011465.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-011465 |
| 2025-03-05 | 21:29 ET | [10-K](/filings/0001628280-25-010506.md) | Annual report, period 2024-12-31 | 0001628280-25-010506 |
| 2025-03-05 | 21:13 ET | [8-K](/filings/0001628280-25-010422.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-010422 |
| 2025-02-12 | 12:22 ET | [8-K](/filings/0001628280-25-005018.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-005018 |
| 2025-01-13 | 12:07 ET | [8-K](/filings/0001628280-25-001229.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001229 |
| 2024-12-19 | 13:02 ET | [8-K](/filings/0001628280-24-051956.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-051956 |
| 2024-12-02 | 13:08 ET | [8-K](/filings/0001628280-24-049497.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-049497 |
| 2024-11-07 | 21:01 ET | [8-K](/filings/0001628280-24-046223.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-046223 |
| 2024-11-06 | 21:01 ET | [8-K](/filings/0001628280-24-045687.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045687 |
| 2024-11-04 | 21:42 ET | [10-Q](/filings/0001628280-24-045030.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045030 |
| 2024-11-04 | 21:40 ET | [8-K](/filings/0001628280-24-045028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045028 |

Page 1 of 5. [Older](/companies/aqst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.